bupleurum
Bupleurum is a large genus of annual or perennial herbs or woody shrubs, with about 190 species, belonging to the family Apiaceae. The full size of its species may vary between a few cm to up to 3 m high. Their compound umbels of small flowers are adorned with bracteoles that are sometimes large and may play a role in attracting pollinators. Rare among the Apiaceae are the simple leaves, bracts, and bracteoles. The genus is almost exclusively native in the Old World Northern Hemisphere, with one species native to North America and one species native to southern Africa. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Earliest trial started May 1, 2008 (NCT01416818)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaBupleurum ↗
Also known as
- bupleurum
- bupleurum
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06725771 | N/A | Sep 1, 2022 | Nanjing Medical University |
| NCT01416818 | Phase 2 | May 1, 2008 | Capital Medical University |
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Nanjing Medical University | Academic/Hospital | 1 | 1 | 1 | 2022 |